Results 261 to 270 of about 2,504,313 (305)
Quality of life of women with gestational diabetes mellitus in a tertiary care hospital, Ajman, UAE: A cross-sectional descriptive study : Quality of life of women with gestational diabetes mellitus. [PDF]
Mandavi RA +4 more
europepmc +1 more source
Aims Vutiglabridin (HSG4112) is a novel drug under clinical development for antiobesity treatment. This study aimed to evaluate the pharmacokinetics (PKs) and safety of vutiglabridin after multiple oral administrations in healthy Korean female and obese subjects and explore short‐term pharmacodynamic (PD) responses.
Sooyoun Lee +5 more
wiley +1 more source
Antioxidant Capacity of Colostrum of Mothers with Gestational Diabetes Mellitus-A Cross-Sectional Study. [PDF]
Gaweł P +3 more
europepmc +1 more source
GLP‐1 agonist‐associated presentations to unscheduled care: An opportunistic pilot study
The impact of GLP‐1 or GIP/GLP‐1 receptor agonist use on unscheduled care is not well‐described. We conducted a prospective, observational study using opportunistic screening by clinicians as a first step to understanding the effect of GLP‐1 or GIP/GLP‐1 agonists on Emergency Department presentations and to guide future studies.
Oliver Thomas, James Michael Coulson
wiley +1 more source
Relationship between serum leptin, lipid metabolism, HbA1c, and renal function in individuals with type 2 diabetes mellitus and obesity and in individuals with type 2 diabetes mellitus without obesity. [PDF]
Akinjinmi AA +7 more
europepmc +1 more source
Objectives This systematic review aims to investigate whether good medication adherence in adults with chronic conditions is associated with a lower mortality risk compared to poor adherence within published literature, and the extent to which this relationship is represented within South African policy and legislation.
Jessica Hamuy Blanco +4 more
wiley +1 more source
Biomaterial design strategies for enhancing mitochondrial transplantation therapy
Biomaterials to facilitate mitochondrial transplantation therapy: biomaterials as barriers to protect mitochondria from pathophysiological microenvironments, like osmotic stress caused by the excessive concentration of calcium ion, reactive oxygen species, and advanced glycation end products; biomaterials integrating with biochemical cues to improve ...
Shaoyang Kang +12 more
wiley +1 more source

